Medical AI startup Qritive has pooled $7.5 million in a funding round led by MassMutual Ventures and supported by Enterprise Singapore's investment arm SEEDS Capital and Exfinity Venture Partners.
WHAT IT DOES
Founded in 2017, the Singapore-headquartered company offers diagnostic support solutions that provide fast and accurate pathological interpretations "within seconds." Its digital pathology...
AI-enabled pathology company PathAI is partnering with the Cleveland Clinic to use its algorithms for clinical care and research.
The five-year collaboration will allow the startup and the academic medical center to digitize "hundreds of thousands" of pathology specimens, creating whole slide images across multiple diseases. When combined with molecular data, the partners will have a large...
Healthcare AI startup Harrison.ai has raised A$129 million ($97 million) in a Series B funding round and teamed up with listed medical diagnostics provider Sonic Healthcare to create new AI tools in pathology.
WHAT IT DOES
Founded in 2018, Harrison.ai is known for its flagship product Annalise CXR, an AI-based clinical decision support tool that reads chest x-rays. The device detects 124 findings...
Israel-based startup Ibex Medical Analytics today announced the first deployment in Switzerland of its artificial intelligence (AI) solution supporting pathologists during routine cancer diagnosis.
Healthcare provider Kantonsspital Baselland (KSBL) will deploy the AI-powered Galen platform, helping pathologists improve accuracy and efficiency during primary cancer diagnosis.
The hospital...
PathAI, maker of AI-enabled pathology products, announced Friday it was partnering with pharma and diagnostics giant Roche.
The strategic partnership will allow PathAI to develop and distribute its AI pathology tech through Roche’s uPath enterprise software, a workflow platform for labs.
The collaboration will begin with distributing PathAI’s research-use-only algorithms through the cloud...
Ibex Medical Analytics, an Israel-based startup using artificial intelligence to support cancer diagnostics, has unveiled a $38 million Series B funding round. Octopus Ventures and 83North led the raise, which also saw participation from aMoon, Planven Entrepreneur Ventures and Dell Technologies Capital.
WHAT IT DOES
Ibex's Galen platform uses AI and machine learning to reduce the burden on...
In its goal to become a full-stack digital health provider, London-based Numan has acquired medical science and healthcare technology company Vi-Health, based in Stockholm and Malmö.
After completion of the acqusition, the majority of the Vi-Health team will be joining Numan, whilst continuing to work from their offices in Sweden.
WHY IT MATTERS
Registered as a Class I medical device, Vi-Health'...
This morning the AI-enabled diagnostic and treatment platform Paige, formerly called Paige.AI, announced a $45 million Series B funding round. The latest raise was led by Healthcare Venture Partners with participation from Breyer Capital, Kenan Turnacioglu and other funders.
Today the company has $70 million in investments. This latest round comes roughly two years after the company closed a $25...
Boston-based PathAI, maker of artificial intelligence tools for pathology, has capped off its Series B funding round with a $15 million strategic investment from the Merck Global Health Innovation Fund and Bristol-Myers Squibb. This raise brings the startup’s full round to $75 million, and its total funding to just over $90 million.
WHAT THEY DO
PathAI’s platform employs convolutional neural...
Yesterday PathAI, a Boston-based maker of artificial intelligence tools for pathology, closed a $60 million Series B funding round led by General Atlantic. Other existing investors, most notably General Catalyst, also participated in the round.
To monitor its investment, General Atlantic Managing Director Dr. Michelle Dipp will also be joining the AI company’s board of directors.
WHAT THEY DO...
